2018 International Congress

Sunday, October 7, 2018

1:45pm-3:15pm

Application of Chinese version of SWAL-QOL in Parkinson’s Disease

H.F. Chan, H. Kim, M. Ng, DY. Kim (Seoul, Republic of Korea)

Quality Of Life/Caregiver Burden in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Approach to Health Care Shaped by Generational Expectations (The AGE Study): Patients’ preferences for healthcare providers

D. Hengartner, T. Rasameesoraj, J. Lin, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

Other  ·  Hall 3FG

1:45pm-3:15pm

Approaching Health Care Shaped by Generational Expectations (The AGE Study): A perspective on technology and research

T. Rasameesoraj, D. Hengartner, J. Lin, O. Hogue, E. LaPlante, Y. Li, O. Wenzel, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

Other  ·  Hall 3FG

1:45pm-3:15pm

Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time

J. Lin, D. Hengartner, T. Rasameesoraj, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)

Other  ·  Hall 3FG

1:45pm-3:15pm

Are Lewy bodies associated with sympathetic pathology in dementia subjects?

D. Shprecher, M. Callan, B. Cutler, G. Serrano, C. Adler, H. Shill, J. Caviness, M. Sabbagh, C. Belden, E. Driver-Dunckley, S. Mehta, L. Sue, K. Davis, E. Zamrini, T. Beach (Sun City, AZ, USA)

Other  ·  Hall 3FG

1:45pm-3:15pm

ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)  ·  Hall 3FG

1:45pm-3:15pm

Arm swing asymmetry in Parkinson Disease patients using a portable RGBD camera

J. Orozco, B. Munoz, J. Valderrama, A. Navarro, Y. Castaño, J. Arango (Cali, Colombia)

Technology  ·  Hall 3FG

1:45pm-3:15pm

Assessing the potential cost-effectiveness of ads-5102 (Amantadine HCl) for the treatment of dyskinesia in Parkinson’s disease patients

R. Pahwa, L. Garrison, M. Zimmerman, R. Johnson, J. Nguyen, M. Li, R. Patni (Kansas City, KS, USA)

Other  ·  Hall 3FG

1:45pm-3:15pm

Assessing the potential of EEG as a biomarker in Huntington’s disease using machine learning automatic classification

O. Odish, K. Johnsen, P. van Someren, R. Roos, G. van Dijk (Leiden, Netherlands)

Huntington's Disease  ·  Hall 3FG

1:45pm-3:15pm

Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment

D. Ceylan, S. Erer, M. Zarifoglu, N. Turkes, A. Demiralay (Bursa, Turkey)

Dystonia  ·  Hall 3FG